-
Cost Utility of Subcutaneous Methotrexate As a Second-Line Treatment for Moderate to Severe Rheumatoid Arthritis in the UK
Sep 9, 2025, 16:22 PM -
Analysis of Pros Included in the HTA Assessment of Conditionally Approved Oncology Drugs in the UK, Italy, and Germany
Sep 9, 2025, 16:22 PM -
Impact Of Dupilumab Treatment On Healthcare Resource Utilization in Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study
Sep 9, 2025, 16:22 PM -
Cost-Substitution and Hospital Diagnosis-Related Group (DRG) Performance Impact Analysis of Infliximab Biosimilar Adoption in Moderate-to-Severe Crohn's Disease Patients in China
Sep 9, 2025, 16:22 PM -
Defining Decision-Making Criteria for Glaucoma Surgery in Non-Refractory, Moderate to Severe Open-Angle Glaucoma: A Stakeholder Analysis Across Multiple Countries with Distinct Payer Archetypes to Support a Multi-Criteria Decision Analysis Framework
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Linzagolix 200 mg Plus Add-back Therapy (Linzagolix+ABT) for Symptomatic Treatment of Endometriosis
Sep 9, 2025, 16:22 PM -
Significant Burden of Chronic Obstructive Pulmonary Disease (COPD) on Health Status and Well-Being Persists Among Patients Experiencing One Severe or Two or More Moderate Exacerbations of COPD (ECOPD) and Their Caregivers (CGs)
Sep 9, 2025, 16:22 PM -
The Evolving Role of Pharmacists as Vaccinators in New Zealand and Denmark
Sep 9, 2025, 16:22 PM -
Unraveling the Challenges of Multiplex Cell Culture Technology Using the HTA Core Model
Sep 9, 2025, 16:22 PM -
Uncovering the Cost Landscape of Congenital Heart Disease (CHD) With a Life Course Perspective: A Systematic Review of Healthcare Utilization by Lesion Type and Age
Sep 9, 2025, 16:22 PM -
A Real-World Survey of Healthcare Resource Utilization Treatment Usage and Unmet Need for Hemophilia Patients in Spain
Sep 9, 2025, 16:22 PM -
The Disease Burden of Respiratory Syncytial Virus Among the Adult Population in Greece
Sep 9, 2025, 16:22 PM -
Trends and Characteristics of Thrombectomy Use in Acute Ischemic Stroke in Germany (2019-2024): Insights From National Claims Data
Sep 9, 2025, 16:22 PM -
The Role of a Functional Clinical Staff in Guiding High-Cost Drug and Novel Technology Decision Making: Experience From a Latin American Oncology Clinic
Sep 9, 2025, 16:22 PM -
Innovation in Off-Patent Competitive Environment: Key Learnings From Successes and Failures
Sep 9, 2025, 16:22 PM -
Unmet Needs in Late-Line Metastatic Colorectal Cancer in Portugal: An Expert-Informed Epidemiological Forecast
Sep 9, 2025, 16:22 PM -
Estimating the Cost-Effectiveness of Tumor-Treating Fields With Gemcitabine and Nabpaclitaxel for Frontline Treatment of Locally Advanced Pancreatic Adenocarcinoma
Sep 9, 2025, 16:22 PM -
Potential Nephrocalcinosis Risk Linked to Nusinersin: Insights from FAERS-Based Signal Detection and Molecular Docking
Sep 9, 2025, 16:22 PM -
The French Transitional Coverage Pathway (PECT) for Innovative Therapeutic Medical Devices: A Four-Year Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Consideration of Off-Label Therapies as Appropriate Comparator Therapy in Early Benefit Assessments in Germany Under the ALBVVG Legislation
Sep 9, 2025, 16:22 PM
